Two-Year Outcomes of a Treat-and-Extend Regimen Using Intravitreal Aflibercept Injections for Typical Age-Related Macular Degeneration.

Ito, Arisa; Matsumoto, Hidetaka; Morimoto, Masahiro; Mimura, Kensuke; Akiyama, Hideo

Ito, Arisa; Matsumoto, Hidetaka; Morimoto, Masahiro; Mimura, Kensuke; Akiyama, Hideo.

Affiliation

Ito A; Department of Ophthalmology, Gunma University School of Medicine, Gunma, Japan.

Ophthalmologica ; 238(4): 236-242, 2017.

Article in En | MEDLINE | ID: mdl-28898873

Subject(s)

Receptors, Vascular Endothelial Growth Factor/administration & dosage; Recombinant Fusion Proteins/administration & dosage; Visual Acuity; Wet Macular Degeneration/drug therapy; Dose-Response Relationship, Drug; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Macula Lutea/pathology; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Wet Macular Degeneration/diagnosis

Key words

Anti-vascular endothelial growth factor; Choroidal neovascularization; Macula; Macular degeneration; Medical treatment of age-related macular degeneration; Optical coherence tomography; Retina

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Visual Acuity / Receptors, Vascular Endothelial Growth Factor / Wet Macular Degeneration Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Ophthalmologica Year: 2017 Document type: Article Affiliation country: Japan Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google